Showing results (91-100 of 448) with videos related to

Sort By:
Pageof 45
Asthma Research and Practice|January 30, 2021
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategyÁlvaro A Cruz, Sara Barile, Elena Nudo, et al.
BMC Pulmonary Medicine|March 19, 2016
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthmaJ Christian Virchow, Roberto Rodriguez-Roisin, Alberto Papi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|April 8, 2026
Bronchopulmonary dysplasia and extremely preterm birth: time for a broader perspective on long-term outcomesLuca Bonadies, Lorenzo Zanetto, Valentina Agnese Ferraro, et al.
International Journal of Molecular Sciences|May 14, 2022
The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPDTommaso Neri, Alessandro Celi, Mariaenrica Tinè, et al.
American Journal of Respiratory and Critical Care Medicine|March 25, 2006
Pulmonary biomarkers in chronic obstructive pulmonary diseasePeter J Barnes, Badrul Chowdhury, Sergei A Kharitonov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 15, 2022
Differences Between Early- and Late-Onset Asthma: Role of Comorbidities in Symptom ControlMartina Turrin, Michele Rizzo, Matteo Bonato, et al.
Recenti Progressi in Medicina|February 11, 2012
[Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema]Gaetano Caramori, Paolo Casolari, Elvira Garofano, et al.
Respiratory Medicine|January 11, 2015
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: a pooled analysisAlberto Papi, David Price, Joaquin Sastre, et al.
BMJ Open Respiratory Research|December 10, 2021
Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA studyBradley E Chipps, Frank C Albers, Laurence Reilly, et al.
Clinical and Translational Allergy|April 22, 2022
Normalisation of airflow limitation in asthma: Post-hoc analyses of TRIMARAN and TRIGGERAlberto Papi, Dave Singh, J Christian Virchow, et al.
Pageof 45